Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Clinical trial NCT00430651 · COMPLETED

Trial details

NCT number: NCT00430651
Sponsor: Hellenic Oncology Research Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2004-07-01
Primary completion: 2008-05-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.